Skip to content

Clinical trials

Phase 1 Bone Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Neoplasms Phase: Phase 1 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20071
20111
20121
20131
20144
20161
20171
20182
20201
20211
20222
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Terminated4
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
National Cancer Institute (NCI)2
University of Southern California2
Boston Scientific Corporation1
Celgene1
Dartmouth-Hitchcock Medical Center1
David Dickens1
Duke University1
Gradalis, Inc.1
InSightec1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Neoplasms23
Sarcoma13
Osteosarcoma7
Melanoma6
Breast Neoplasms5
Lung Neoplasms3
Neoplasms3
Neuroectodermal Tumors, Primitive, Peripheral3
Prostatic Neoplasms3
Skin Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.